4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004502
See Remarks sold 6,537 shares at an average $5.09 ($33,287)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sinha Vikas See Remarks | 2023-01-19 | Sale | −5,111 | $5.08 | $25,952 | 1,031,664 | D: show line 1 in the form |
| Sinha Vikas See Remarks | 2023-01-20 | Sale | −1,426 | $5.14 | $7,335 | 1,030,238 | D: show line 2 in the form |
| Open-market sales · 6,537 sh · avg $5.09 · $33,287 | |||||||
Loading xslF345X03/doc4.xml…